Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Harvard Business School
Mallinckrodt
Johnson and Johnson
Boehringer Ingelheim

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for erythromycin ethylsuccinate; sulfisoxazole acetyl and what is the scope of patent protection?

Erythromycin ethylsuccinate; sulfisoxazole acetyl is the generic ingredient in three branded drugs marketed by Barr, Alra, and Ross Labs, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and three drug master file entries for erythromycin ethylsuccinate; sulfisoxazole acetyl.

Summary for ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL
US Patents:0
Tradenames:3
Applicants:3
NDAs:3
Drug Master File Entries: 103
DailyMed Link:ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL at DailyMed

US Patents and Regulatory Information for ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alra ERYZOLE erythromycin ethylsuccinate; sulfisoxazole acetyl GRANULE;ORAL 062758-001 Jun 15, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Ross Labs PEDIAZOLE erythromycin ethylsuccinate; sulfisoxazole acetyl GRANULE;ORAL 050529-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Barr ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL erythromycin ethylsuccinate; sulfisoxazole acetyl GRANULE;ORAL 062759-001 May 20, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Boehringer Ingelheim
Dow
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.